Latest News for: esgct

Edit

ESGCT 2025 (CTX460) (4b76e9) (CRISPR Therapeutics AG)

Public Technologies 10 Oct 2025
) Single-dose in-vivo gene correction of AATD via LNP-delivered SyNTaseTM editors. CRISPR THERAPEUTICS - CONFIDENTIAL 1. ESGCT Congress Christof Fellmann, PhD Seville, 2025. Bringing next-generation genome editing to patients ... Delivery via IV injection.
Edit

Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress (Form 8-K) (Editas Medicine Inc)

Public Technologies 09 Oct 2025
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress ... Abstracts are available to registrants on the ESGCT website.
Edit

Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress (Form 8-K) (Cabaletta Bio Inc)

Public Technologies 09 Oct 2025
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress ... Additional information can be accessed on the website of the 2025 ESGCT Annual Congress.
Edit

ESGCT 2025 HLH Combined vFinal Print (Neurogene Inc)

Public Technologies 09 Oct 2025
). ‌Rett Syndrome and Rationale for Gene Therapy. HLH Has Been Rarely Reported Following High-dose AAV Gene Therapy. Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder, occurring predominately in females caused by mutations in the.
Edit

Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025 (Circio Holding ASA)

Public Technologies 08 Oct 2025
) ... Subscribe. Issuer ... Society of Cell and Gene Therapy (ESGCT) annual meeting 2025 in Seville, ... In the ESGCT poster presentation, Circio is presenting new and expanded in ... "ESGCT provides an excellent forum to showcase the circVec platform to a wide.
Edit

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT ...

Nasdaq Globe Newswire 07 Oct 2025
... European Society of Cell and Gene Therapy (ESGCT) annual congress, that will take place on October 7-10, 2025, in Sevilla, Spain.
Edit

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual

Hastings Tribune 07 Oct 2025
NEW YORK, Oct ... ALCLS - NASDAQ.
Edit

SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, ...

The Joplin Globe 07 Oct 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 7, 2025-- ... .
Edit

MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 ...

Nasdaq Globe Newswire 07 Oct 2025
Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms. Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms ... .
Edit

AAVantgarde announces 3 presentations at ESGCT 2025 annual meeting

Nasdaq Globe Newswire 07 Oct 2025
... Meeting (ESGCT), to be held October 7-10 in Seville (Spain).
Edit

Coave Therapeutics demonstrates superiority of its novel suprachoroidal capsid at ESGCT Congress 2025

Nasdaq Globe Newswire 07 Oct 2025
PARIS, France – 7 October 2025 ... .
Edit

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress (Form 6-K) (Cellectis SA)

Public Technologies 07 Oct 2025
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress ... Therapy (ESGCT) annual congress, that will take place on October 7-10, 2025, in Sevilla, Spain.
Edit

Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress (Syncona Ltd)

Public Technologies 07 Oct 2025
These data are being presented at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress in Seville, Spain ... "The data being presented at ESGCT show that a single infusion of ...
Edit

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress (Cellectis SA)

Public Technologies 07 Oct 2025
PRESS RELEASE Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress.
Edit

Theriva™ Biologics anuncia la presentación del VCN-12, un adenovirus oncolítico de nueva generación, en el 32.º Congreso Anual de la Sociedad Europea de Terapia Génica y Celular (ESGCT) (Theriva Biologics Inc)

Public Technologies 06 Oct 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 126880762) .

Article Search

tools
×
×
×
×